These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
426 related items for PubMed ID: 8062273
41. TGF-beta control of rat thyroid follicular cells differentiation. Nicolussi A, D'Inzeo S, Santulli M, Colletta G, Coppa A. Mol Cell Endocrinol; 2003 Sep 30; 207(1-2):1-11. PubMed ID: 12972178 [Abstract] [Full Text] [Related]
42. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype. Elisei R, Pinchera A, Romei C, Gryczynska M, Pohl V, Maenhaut C, Fugazzola L, Pacini F. J Clin Endocrinol Metab; 1994 Apr 30; 78(4):867-71. PubMed ID: 8157713 [Abstract] [Full Text] [Related]
43. Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin. Bruno R, Ferretti E, Tosi E, Arturi F, Giannasio P, Mattei T, Scipioni A, Presta I, Morisi R, Gulino A, Filetti S, Russo D. J Clin Endocrinol Metab; 2005 Oct 30; 90(10):5692-7. PubMed ID: 16076943 [Abstract] [Full Text] [Related]
44. Expression of thyroid-specific transcription factors in thyroid carcinoma, contralateral thyroid lobe and healthy thyroid gland in dogs. Pessina P, Castillo V, Araújo M, Carriquiry M, Meikle A. Res Vet Sci; 2012 Aug 30; 93(1):108-13. PubMed ID: 21737109 [Abstract] [Full Text] [Related]
45. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells. Taki K, Kogai T, Kanamoto Y, Hershman JM, Brent GA. Mol Endocrinol; 2002 Oct 30; 16(10):2266-82. PubMed ID: 12351692 [Abstract] [Full Text] [Related]
46. TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Di Palma T, D'Andrea B, Liguori GL, Liguoro A, de Cristofaro T, Del Prete D, Pappalardo A, Mascia A, Zannini M. Exp Cell Res; 2009 Jan 15; 315(2):162-75. PubMed ID: 19010321 [Abstract] [Full Text] [Related]
47. Mediation of the hormone- and serum-dependent regulation of thyroglobulin gene expression by thyroid-transcription factors in rat thyroid FRTL-5 cells. Kambe F, Seo H. J Endocrinol; 1996 Aug 15; 150(2):287-98. PubMed ID: 8869595 [Abstract] [Full Text] [Related]
48. Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid. Cimino-Mathews A, Sharma R, Netto GJ. Am J Surg Pathol; 2011 May 15; 35(5):757-61. PubMed ID: 21451364 [Abstract] [Full Text] [Related]
49. Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution. Lew M, Pang JC, Roh MH, Jing X. Acta Cytol; 2015 May 15; 59(5):412-7. PubMed ID: 26587773 [Abstract] [Full Text] [Related]
50. Adenovirus-mediated transfer of thyroid transcription factor-1 induces radioiodide organification and retention in thyroid cancer cells. Furuya F, Shimura H, Miyazaki A, Taki K, Ohta K, Haraguchi K, Onaya T, Endo T, Kobayashi T. Endocrinology; 2004 Nov 15; 145(11):5397-405. PubMed ID: 15271884 [Abstract] [Full Text] [Related]
51. Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material. Sathiyamoorthy S, Maleki Z. Diagn Cytopathol; 2014 Jan 15; 42(1):5-10. PubMed ID: 23637102 [Abstract] [Full Text] [Related]
52. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas. Chernock RD, El-Mofty SK, Becker N, Lewis JS. Am J Surg Pathol; 2013 Aug 15; 37(8):1215-22. PubMed ID: 23681073 [Abstract] [Full Text] [Related]
53. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma]. Umeki K, Yamamoto I, Maruta J, Aratake Y, Ono I, Uemura Y, Tanaka T, Toyoda K, Kotani T, Noguchi S, Sakamoto F, Konoe K, Ohtaki S. Rinsho Byori; 1996 Jan 15; 44(1):42-50. PubMed ID: 8691639 [Abstract] [Full Text] [Related]
54. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells. Ma R, Latif R, Davies TF. Thyroid; 2013 Apr 15; 23(4):385-91. PubMed ID: 23360087 [Abstract] [Full Text] [Related]
55. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG, Nikiforov YE. J Clin Endocrinol Metab; 2003 May 15; 88(5):2318-26. PubMed ID: 12727991 [Abstract] [Full Text] [Related]
56. Thyroid-specific gene expression in chondrocytes. Endo T, Kobayashi T. Biochem Biophys Res Commun; 2011 Dec 16; 416(3-4):227-31. PubMed ID: 21945616 [Abstract] [Full Text] [Related]
57. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines. Takano T, Ito Y, Matsuzuka F, Miya A, Kobayashi K, Yoshida H, Miyauchi A. Oncol Rep; 2007 Sep 16; 18(3):715-20. PubMed ID: 17671725 [Abstract] [Full Text] [Related]
58. Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction. D'Andrea B, Iacone R, Di Palma T, Nitsch R, Baratta MG, Nitsch L, Di Lauro R, Zannini M. Mol Endocrinol; 2006 Aug 16; 20(8):1810-24. PubMed ID: 16613988 [Abstract] [Full Text] [Related]
59. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression. Batista FA, Ward LS, Marcello MA, Martins MB, Peres KC, Torricelli C, Bufalo NE, Soares FA, da Silva MJ, Assumpção LV. J Endocrinol Invest; 2016 Apr 16; 39(4):423-9. PubMed ID: 26370671 [Abstract] [Full Text] [Related]
60. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma. Mirebeau-Prunier D, Guyétant S, Rodien P, Franc B, Baris O, Rohmer V, Reynier P, Tourmen Y, Malthièry Y, Savagner F. Eur J Endocrinol; 2004 Mar 16; 150(3):269-76. PubMed ID: 15012610 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]